Literature DB >> 27247838

Long-Term Treatment of Clozapine-Induced Leukopenia With Lithium: Fast-Onset Agranulocytosis Following Lithium Discontinuation.

Rémy Dumas1, Pierre Bardin1, Christian Vedie1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27247838      PMCID: PMC4874758          DOI: 10.4088/PCC.15l01841

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN: 2155-7780


× No keyword cloud information.
  5 in total

1.  Safety and efficacy of combined clozapine-lithium pharmacotherapy.

Authors:  Stefan Bender; Thomas Linka; Jörg Wolstein; Susanne Gehendges; Hermann-Josef Paulus; Ulrich Schall; Markus Gastpar
Journal:  Int J Neuropsychopharmacol       Date:  2004-01-20       Impact factor: 5.176

2.  Rechallenging with clozapine following neutropenia: treatment options for refractory schizophrenia.

Authors:  Sharmin Ghaznavi; Marina Nakic; Paul Rao; Jian Hu; Judson A Brewer; Jonas Hannestad; Zubin Bhagwagar
Journal:  Am J Psychiatry       Date:  2008-07       Impact factor: 18.112

Review 3.  Molecular targets of lithium action.

Authors:  C J Phiel; P S Klein
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

Review 4.  Maximizing clozapine therapy: managing side effects.

Authors:  J A Lieberman
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

5.  Tolerability and efficacy of clozapine combined with lithium in schizophrenia and schizoaffective disorder.

Authors:  Joyce G Small; Marietta H Klapper; Frederick W Malloy; Timothy M Steadman
Journal:  J Clin Psychopharmacol       Date:  2003-06       Impact factor: 3.153

  5 in total
  1 in total

1.  Clozapine re-challenge and initiation following neutropenia: a review and case series of 14 patients in a high-secure forensic hospital.

Authors:  Edward Silva; Melanie Higgins; Barbara Hammer; Paul Stephenson
Journal:  Ther Adv Psychopharmacol       Date:  2021-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.